Vendor, Santa Monica, CA
Opiant Pharmaceuticals, Inc.
UEI KM23KYBML5N8, CAGE 73QL8
1 award and -$95,516 obligated between January 2, 2024 and January 2, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$95,516 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$95,516 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50118D00029January 2, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | De-Obligate $95,516.40 from Clin 0003 Option 2 for Closeout.NAICS 541715, PSC AN13 | -$95,516 |
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards